| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 05/09/2002 | US20020054870 A peptide containing atleast 6 amino acid residues, having 70% homology with part or all of the sequence containing specific 14 amino acids |
| 05/09/2002 | US20020054869 Inhibition of mitogen-activated protein kinase (MAPK) pathway: a selective therapeutic strategy against melanoma |
| 05/09/2002 | US20020054855 Gastrin receptor-avid peptide conjugates |
| 05/09/2002 | US20020054852 A carrier material reflects or absorbs or emits electromagnetic or mechanical vibration enabling the monitoring of carrier material and a drug associated with carrier, and a targeting agent bind to the site |
| 05/08/2002 | EP1203819A2 Anti-inflammatory vectors |
| 05/08/2002 | EP1203817A2 Compounds and methods for immunotherapy and diagnosis of tuberculosis |
| 05/08/2002 | EP1203816A1 Amyloid beta protein agglutination controlling factor |
| 05/08/2002 | EP1203813A2 Attenuated pestiviruses |
| 05/08/2002 | EP1203812A2 Attenuated pestiviruses |
| 05/08/2002 | EP1203775A2 Lymphocyte chemoattractant factor and uses thereof |
| 05/08/2002 | EP1203774A1 Process for removing protein aggregates and virus from a protein solution |
| 05/08/2002 | EP1203591A1 Ionic molecular conjugates of biodegradable polyesters and bioactive polypeptides |
| 05/08/2002 | EP1203588A1 Sterol-independent regulation of ABC1 promoter via oncostatinM |
| 05/08/2002 | EP1203586A2 Compositions comprising a mast cell degranulation-blocking agent for treatment of endogenous, painful gastrointestinal conditions of non-inflammatory, non-ulcerative origin. |
| 05/08/2002 | EP1203239A2 Use of a polypeptide for detecting, preventing or treating a pathological condition associated with a degenerative, neurological or autoimmune disease |
| 05/08/2002 | EP1203081A2 Human intracellular signaling molecules |
| 05/08/2002 | EP1203074A1 Compositions and methods for forming and strengthening bone |
| 05/08/2002 | EP1203026A1 Binding moieties for fibrin |
| 05/08/2002 | EP1203025A2 NOVEL METHOD AND COMPOSITION FOR INHIBITION OF ANGIOGENESIS USING ANTAGONISTS BASED ON MMP-9 AND $g(b)1 INTEGRINS |
| 05/08/2002 | EP1203024A1 Human tumor necrosis factor receptors tr13 and tr14 |
| 05/08/2002 | EP1203023A1 Pgpcr-3 polypeptides and dna sequences thereof |
| 05/08/2002 | EP1203020A1 Modulation of human sodium channels in dorsal root ganglia |
| 05/08/2002 | EP1203019A1 Peptides containing n-substituted l-amino acids for preventing beta-strand association |
| 05/08/2002 | EP1203018A1 26 human prostate and prostate cancer associated proteins |
| 05/08/2002 | EP1203016A2 Proteases and protease inhibitors |
| 05/08/2002 | EP1203015A2 Human chaperone proteins |
| 05/08/2002 | EP1203014A2 Peptide antagonists of factor viia |
| 05/08/2002 | EP1203013A1 Kinase blocking polypeptides and uses thereof |
| 05/08/2002 | EP1203010A1 Antisense modulation of fadd expression |
| 05/08/2002 | EP1203009A1 Antisense modulation of jun n-terminal kinase kinase-1 expression |
| 05/08/2002 | EP1203007A1 Nucleic acid ligands to hepatocyte growth factor/scatter factor (hgf/sf) or its receptor c-met and to integrins |
| 05/08/2002 | EP1203005A2 25 human secreted proteins |
| 05/08/2002 | EP1203004A1 HIGH AFFINITY TGF$g(g) NUCLEIC ACID LIGANDS AND INHIBITORS |
| 05/08/2002 | EP1202976A1 Pyrazinones, compositions containing such compounds |
| 05/08/2002 | EP1202970A1 Cyclic amine derivatives for the treatment of neurological diseases |
| 05/08/2002 | EP1202748A2 Polycation-based bioconjugates |
| 05/08/2002 | EP1202744A2 PRODUCTION OF rhPBGD AND NEW THERAPEUTIC METHODS FOR TREATING PATIENTS WITH ACUTE INTERMITTENT PORPHYRIA (AIP) AND OTHER PORPHYRIC DISEASES |
| 05/08/2002 | EP1202743A2 Fish serine proteinases and their pharmaceutical and cosmetic use |
| 05/08/2002 | EP1202741A1 Neurotropic virus transport |
| 05/08/2002 | EP1202737A2 Antiviral therapy use of p-glycoprotein modulators |
| 05/08/2002 | EP1202736A1 Nicotine in therapeutic angiogenesis and vasculogenesis |
| 05/08/2002 | EP1202730A2 Use of ep4 receptor ligands in the treatment of neuropathic pain and colon cancer |
| 05/08/2002 | EP1202620A1 Anti-inflammatory therapy for inflammatory mediated infection |
| 05/08/2002 | EP1043322B1 Vitamin e derivatives |
| 05/08/2002 | EP1024823B1 Prevention and treatment of adhesion formation |
| 05/08/2002 | EP0998299A4 ISOLATED PEPTIDES WHICH COMPLEX WITH HLA-Cw*16 MOLECULES, AND USES THEREOF |
| 05/08/2002 | EP0915648B1 Methods and compositions for the selective modification of nucleic acids |
| 05/08/2002 | EP0914332B1 Isoquinolines useful as analgesics |
| 05/08/2002 | EP0895545A4 Novel protein - traf6 |
| 05/08/2002 | EP0804464B1 Aromatic heterocyclic derivatives as enzyme inhibitors |
| 05/08/2002 | EP0789783B1 Antigen binding peptides (abtides) from peptide libraries |
| 05/08/2002 | EP0726766B1 Novel pharmaceutical composition containing the ace inhibitor ramipril and a dihydropyridine compound |
| 05/08/2002 | EP0723545B1 Quinolizinone type compounds |
| 05/08/2002 | EP0721505B1 Purified hepatitis c virus envelope proteins for diagnostic and therapeutic use |
| 05/08/2002 | EP0708653B1 Assay and reagents for identifying anti-proliferative agents |
| 05/08/2002 | EP0629240B1 Altered antibodies, products and processes relating thereto |
| 05/08/2002 | EP0625053B1 Urease-based vaccine against helicobacter infection |
| 05/08/2002 | DE10055705A1 Inhibiting rejection of transplanted organs by additionally transplanting rapidly dividing tissue, preferably stem cells, from the same donor |
| 05/08/2002 | DE10053870A1 Procollagen (III)-Propeptide und verwandte Substanzen zur Behandlung von fibrotischen Erkrankungen Procollagen (III) propeptides and related substances for the treatment of fibrotic diseases |
| 05/08/2002 | DE10053251A1 New protein or peptide comprising epitope of plasminogen activator inhibitor-1, useful for screening substance for treating thromboembolic and cardiovascular diseases, cancer or related diseases |
| 05/08/2002 | CN1348498A Novel Nucleic acid transferring agents, compsoitions containing them and uses |
| 05/08/2002 | CN1348496A Viral vaccine |
| 05/08/2002 | CN1348492A Pseudomycin production by i(pseudomonas syringae) |
| 05/08/2002 | CN1348466A Epitopes or mimotopes derived from the c-epsilon-2-domain of IgE, antagonists thereof, and their therapeutic uses |
| 05/08/2002 | CN1348465A Treatment of fibrosis by antagonism of IL-13 and IL-13 receptor chains |
| 05/08/2002 | CN1348464A Compositions and methods using lactadherin or variants thereof |
| 05/08/2002 | CN1348463A Immunological herpes simplex virus antigens and methods for use thereof |
| 05/08/2002 | CN1348462A Novel LHRH-antagonists with improved solubility characteristics |
| 05/08/2002 | CN1348383A Prolonged release microsphere encapsulating luteinizing hormone-releasing hormone analogues and method for preparing the same |
| 05/08/2002 | CN1348382A Methods for administration of antibiotics |
| 05/08/2002 | CN1348381A Treatment with small peptides to effect antifibrotic activity |
| 05/08/2002 | CN1348376A Method for validating/invalidating target(s) and pathways |
| 05/08/2002 | CN1348003A Hirudin gene hv 2-47k and its synthesis and expression |
| 05/08/2002 | CN1348002A New polypeptide human ATP dependent serine proteinase 30.58 and polynucleotides for encoding this polypeptide |
| 05/08/2002 | CN1348001A New polypeptide signalase 9.35 and polynucleotides for encoding this polypeptide |
| 05/08/2002 | CN1347999A New polypeptide human glycosylhydrolase 13.64 and polynucleotides for encoding this polypeptide |
| 05/08/2002 | CN1347998A New polypeptide human phosphatase 32.01 and polynucleotides for encoding this polypeptide |
| 05/08/2002 | CN1347997A New polypeptide Rap phosphatase 8.8 containing TPRs structural domain and polynucleotides for encoding this polypeptide |
| 05/08/2002 | CN1347996A New polypeptide thioesterase II 36.52 and polynucleotides for encoding this polypeptide |
| 05/08/2002 | CN1347995A New polypeptide serine/threonine protein kinase 23.32 and polynucleotides for encoding this polypeptide |
| 05/08/2002 | CN1347994A New polypeptide human P70 ribosome S6 kinase 26.29 and polynucleotides for encoding this polypeptide |
| 05/08/2002 | CN1347993A New polypeptide SR protein specific serine kinase 17.49 and polynucleotides for encoding this polypeptide |
| 05/08/2002 | CN1347992A New polypeptide human ribosome S6 serine-threonine protein kinase 9.46 and polynucleotides for encoding this polypeptide |
| 05/08/2002 | CN1347991A New polypeptide hexokinase protein 10.78 and polynucleotides for encoding this polypeptide |
| 05/08/2002 | CN1347990A New polypeptide human dehydrogenase 12.76 and polynucleotides for encoding this polypeptide |
| 05/08/2002 | CN1347989A New polypeptide nucleotide reductase 16.83 and polynucleotides for encoding this polypeptide |
| 05/08/2002 | CN1347988A New polypeptide quinoprotein reductase 17.05 and polynucleotides for encoding this polypeptide |
| 05/08/2002 | CN1347987A New polypeptide aldehyde/ketone reductase 9.46 and polynucleotides for encoding this polypeptide |
| 05/08/2002 | CN1347986A New polypeptide hydrogenase 11.66 and polynucleotides for encoding this polypeptide |
| 05/08/2002 | CN1347985A New polypeptide argininoacyl tRNA synthetase 12.87 and polynucleotides for encoding this polypeptide |
| 05/08/2002 | CN1347734A Method for treating thrombosis diseases |
| 05/08/2002 | CN1084209C High polymer antineoplastic guide medicine and preparation thereof |
| 05/08/2002 | CN1084193C Medicine for lowering blood-sugar and nourishing heart and preparing method |
| 05/07/2002 | US6384204 Oligonucleotides of defined nucleotide sequence; from gene sequences of transcription factor for serotonergic neurons |
| 05/07/2002 | US6384203 Family of immunoregulators designated leukocyte immunoglobulin-like receptors (LIR) |
| 05/07/2002 | US6384202 Cell-specific active compounds regulated by the cell cycle |
| 05/07/2002 | US6384200 Lysing amebocytes from horseshoe crab using hypotonic shock, extracting cell debris with urea or guanidine hydrochloride, and purifying using ultrafiltration membranes and chromatography steps |
| 05/07/2002 | US6384198 Methods for inhibiting the production of HIV-1 retrovirus using monoclonal antibodies and Fv specific for CD2 antigen |
| 05/07/2002 | US6384195 Produced by partitioning method; therapeutics |
| 05/07/2002 | US6384193 Agents for the regulation of oestrogen synthesis |